| EOC | Epithelial ovarian cancer |
| BM-MSCs | Bone-Marrow-Derived Mesenchymal Stem Cells |
| AOCS | Australian Ovarian Cancer Study |
| TME | Tumor Micro-Environment |
| EMT | Epithelial-Mesenchymal Transition |
| ECM | Extra-Cellular Matrix |
| CCL | Chemokine, C-C motif, Ligand |
| Th17 | T-helper 17 |
| HPV | Human Papilloma Virus |
| α-SMA | Alpha Smooth Muscle Actin |
| PDGFβR | Platelet Derived Growth Factor Beta Receptor |
| CAFs | Cancer-Associated Fibroblasts |
| FAP | Fibroblast Activation Protein |
| MCAM/CD146 | Melanoma Cell Adhesion Molecule/ Cluster of Differentiation 146 |
| CD | Cluster of Differentiation |
| FGF/FGFR | Fibroblast Growth Factor/ Fibroblast Growth Factor Receptor |
| VCAN | VersiCAN gene |
| VEGF-A | Vascular Endothelial Growth Factor-A |
| CXCL | Chemokine C-X-C motif ligand |
| PFS | Progression Free Survival |
| OS | Overall Survival |
| LCA | Leukocyte Common Antigen |
| TILs | Tumor-Infiltrating Lymphocytes |
| Tregs | T-regulatory cells |
| NK | Natural Killer |
| HSGC | High Serous Grade Carcinoma |
| TRM | Tissue Resident Memory |
| HLA | Human Leucocyte Antigens |
| IL | InterLeukin |
| INF γ | INterFeron γ |
| PD-L1 | PD- Ligand 1 |
| CTLA | Cytotoxic T-Lymphocyte-Associated Protein 4 |
| MHC | Major Histocompatibility Complex |
| TP53 | Tumor Protein 53 |
| APCs | Antigen-Presenting-Cells |
| FOXP3 | Fork Head Box 3 |
| TGF-β | Tumor Grow Factor β |
| TAMs | Tumor-Associated Macrophages |
| VEGF | Vascular Endothelial Growth Factor |
| TNF | Tumor Necrosis Factor |
| PLCγ | PhosphoLipase Cγ |
| JAK/ STAT | JAnus Kinase/Signal Transducer and Activator of Transcription |
| PI3K | PhosphoInositide 3 Kinase |
| Tim-3 | T-cell immunoglobulin and mucin-domain-containing-3 |
| MIC A/B | Major histocompatibility complex class I-related chains (MIC) A and B |
| ULBPs | UL-16 binding proteins |
| NKG2D | Natural killer group 2, member D |
| EC | Endometrial Cancer |
| PTEN | Phosphatase and Tensin homolog |
| CTNNB1 | Catenin Beta 1 |
| PIK3CA | Phosphatidylinositol 3-kinase |
| MLH1 | MutL Homolog 1 |
| POLE | DNA POLymerase Epsilon |
| HNPCC | Hereditary Non-Polyposis Colon Cancer |
| ER α | Estrogen Receptor α |
| ESR1 | (gene) EStrogen Receptor 1 |
| E2 | 17β-estradiol |
| IGF1 | Insulin-like Growth Factor 1 |
| TGF | Tumor Growth Factor |
| MAD2L1 | Mitotic Arrest Deficient 2 Like 1 |
| CDKN1A | Cyclin-Dependent Kinase Inhibitor 1A |
| EH | Endometrial Hyperplasia |
| PR | Progesterone Receptor |
| CCx | Cervical cancer |
| pRB | Retinoblastoma protein |
| MCP1 | Monocyte Chemoattractant Protein 1 |
| MIP3A | Macrophage Inflammatory Protein-3α |
| HSIL | High-grade Squamous Intraepithelial Lesion |
| CCR | C-C motif Chemokine Receptor |
| LSIL | Low-grade Squamous Intraepithelial Lesion |
| C/EBPβ | CCAAT Enhancer Binding Protein Beta |
| MMP-9 | Matrix-Metalloproteinase |
| FIGO | International Federation of Gynaecology and Obstetrics |
| THBS | Thrombospondins |
| EGFR | Epidermal growth factor receptor |
| HBEGF | Heparin Binding EGF Like Growth Factor |
| FGF9 | Fibroblast Growth Factor 9 |
| PUFAs | Polyunsaturated Fatty Acids |
| Evs | Extracellular Vesicles |
| VEGFR | Vascular Endothelial Growth Factor Receptor |
| EGF | Endothelial Growth Factor |
| EGFR | Endothelial Growth Factor Receptor |
| PCX | Paclitaxel |
| TLR | Toll-Like Receptor |
| SIRPα | Signal-Regulatory Protein Alpha |
| CSF-1 | Colony-Stimulating Factor 1 |
| CSF1-R | Colony-Stimulating Factor 1 Receptor |
| LVSI | LymphoVascular Space Invasion |
| MET | Mesenchymal-epithelial transition |